[go: up one dir, main page]

Sarepta surges on $1.15B deal with pharma giant Roche

Sarepta shares are soaring after it struck a $1.15 billion licensing agreement with Roche. The deal will launch Sarepta's gene therapy treatment for muscular dystrophy outside of the U.S. Yahoo Finance's Ines Ferre joins Seana Smith to discuss on The Ticker.